Miguel Godinho Ferreira

Dr. Miguel Godinho Ferreira

IRCAN - Institute for Research on Cancer and Aging of Nice
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2023 in Science
Verified
Journal Article
Closed access
PSParminder Singh
Parminder Singh
KGKishore Gollapalli
Kishore Gollapalli
SMStefano Mangiola
Stefano Mangiola
DSDaniela Schranner
Daniela Schranner
MYMohd Aslam Yusuf
Mohd Aslam Yusuf
Vijay YadavVijay Yadav
Vijay Yadav
Aging is associated with changes in circulating levels of various molecules, some of which remain undefined. We find that concentrations of circulating taurine decline with aging in mice, monkeys, and humans. A reversal of this decline through taurine supplementation increased the health span (the period of healthy living) and life span in mice and health span in monkeys. Mechanistically, taurine reduced cellular senescence, protected against telomerase deficiency, suppressed mitochondrial dysfunction, decreased DNA damage, and attenuated inflammaging. In humans, lower taurine concentrations correlated with several age-related diseases and taurine concentrations increased after acute endurance exercise. Thus, taurine deficiency may be a driver of aging because its reversal increases health span in worms, rodents, and primates and life span in worms and rodents. Clinical trials in humans seem warranted to test whether taurine deficiency might drive aging in humans.

23 August 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Rita FiorRita Fior
Rita Fior
VPVanda Póvoa
Vanda Póvoa
RMRaquel V. Mendes
Raquel V. Mendes
TCTânia Carvalho
Tânia Carvalho
AGAntonio Gomes
Antonio Gomes
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
Cancer is as unique as the person fighting it. With the exception of a few biomarker-driven therapies, patients go through rounds of trial-and-error approaches to find the best treatment. Using patient-derived cell lines, we show that zebrafish larvae xenotransplants constitute a fast and highly sensitive in vivo model for differential therapy response, with resolution to reveal intratumor functional cancer heterogeneity. We screened international colorectal cancer therapeutic guidelines and determined distinct functional tumor behaviors (proliferation, metastasis, and angiogenesis) and differential sensitivities to standard therapy. We observed a general higher sensitivity to FOLFIRI [5-fluorouracil(FU)+irinotecan+folinic acid] than to FOLFOX (5-FU+oxaliplatin+folinic acid), not only between isogenic tumors but also within the same tumor. We directly compared zebrafish xenografts with mouse xenografts and show that relative sensitivities obtained in zebrafish are maintained in the rodent model. Our data also illustrate how KRAS mutations can provide proliferation advantages in relation to KRASWT and how chemotherapy can unbalance this advantage, selecting for a minor clone resistant to chemotherapy. Zebrafish xenografts provide remarkable resolution to measure Cetuximab sensitivity. Finally, we demonstrate the feasibility of using primary patient samples to generate zebrafish patient-derived xenografts (zPDX) and provide proof-of-concept experiments that compare response to chemotherapy and biological therapies between patients and zPDX. Altogether, our results suggest that zebrafish larvae xenografts constitute a promising fast assay for precision medicine, bridging the gap between genotype and phenotype in an in vivo setting. Significance Despite advances in targeted cancer treatments, we still lack methods to predict how a specific cancer will respond to a given therapy. As a consequence, patients go through rounds of trial-and-error approaches based on guidelines to find the best treatment, often subjected to unnecessary toxicity. Using cell lines, we used zebrafish larvae xenografts as sensors for cancer behavior and therapy guideline screening. Our data show not only sufficient resolution to distinguish functional tumor behaviors in just 4 days but also differential sensitivity to colorectal cancer therapy. As proof-of-principle, we provide evidence for similar behavior response to therapies in patients as in zebrafish patient-derived xenografts. Altogether, our results suggest zebrafish larvae xenografts as a promising in vivo screening platform for precision medicine.

24 July 2009 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
STSandra Trindade
Sandra Trindade
ASAna Sousa
Ana Sousa
KXKarina B. Xavier
Karina B. Xavier
FDFrancisco Dionisio
Francisco Dionisio
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
IGIsabel Gordo
Isabel Gordo
The evolution of multiple antibiotic resistance is an increasing global problem. Resistance mutations are known to impair fitness, and the evolution of resistance to multiple drugs depends both on their costs individually and on how they interact—epistasis. Information on the level of epistasis between antibiotic resistance mutations is of key importance to understanding epistasis amongst deleterious alleles, a key theoretical question, and to improving public health measures. Here we show that in an antibiotic-free environment the cost of multiple resistance is smaller than expected, a signature of pervasive positive epistasis among alleles that confer resistance to antibiotics. Competition assays reveal that the cost of resistance to a given antibiotic is dependent on the presence of resistance alleles for other antibiotics. Surprisingly we find that a significant fraction of resistant mutations can be beneficial in certain resistant genetic backgrounds, that some double resistances entail no measurable cost, and that some allelic combinations are hotspots for rapid compensation. These results provide additional insight as to why multi-resistant bacteria are so prevalent and reveal an extra layer of complexity on epistatic patterns previously unrecognized, since it is hidden in genome-wide studies of genetic interactions using gene knockouts. Understanding the nature of genetic interactions, known as epistasis, is crucial in biology. The strength and type of epistasis is relevant for the evolution of sex, buffering of genetic variation, speciation, and the topography of fitness landscapes. While epistasis between gene deletions has been the recent focus of research, interactions between randomly selected alleles, which are of the greatest evolutionary interest, have not. We have studied the strength and type of epistasis amongst alleles that confer antibiotic resistance and have found that: in an antibiotic-free environment, the cost of multiple resistance is smaller than expected—a signature of pervasive positive epistasis amongst alleles that confer resistance to antibiotics; epistatic interactions are allele specific; a significant fraction of resistant mutations can be beneficial in certain resistant genetic backgrounds; some double resistances entail no measurable cost; and some allelic combinations are hotspots for rapid compensation. Overall, our findings provide added reasoning as to why multi-resistance is so difficult to eradicate. Importantly, our results of allelic-specific epistasis reveal an extra layer of complexity on epistatic patterns previously unrecognized.

15 March 2013 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MMMichal Malecki
Michal Malecki
SVSandra C. Viegas
Sandra C. Viegas
TCTiago Carneiro
Tiago Carneiro
PGPawel Golik
Pawel Golik
CDClémentine Dressaire
Clémentine Dressaire
CACecília Maria Arraiano
Cecília Maria Arraiano
The final step of cytoplasmic mRNA degradation proceeds in either a 5′‐3′ direction catalysed by Xrn1 or in a 3′‐5′ direction catalysed by the exosome. Dis3/Rrp44, an RNase II family protein, is the catalytic subunit of the exosome. In humans, there are three paralogues of this enzyme: DIS3, DIS3L, and DIS3L2. In this work, we identified a novel Schizosaccharomyces pombe exonuclease belonging to the conserved family of human DIS3L2 and plant SOV. Dis3L2 does not interact with the exosome components and localizes in the cytoplasm and in cytoplasmic foci, which are docked to P‐bodies. Deletion of dis3l2+ is synthetically lethal with xrn1 Δ, while deletion of dis3l2+ in an lsm1 Δ background results in the accumulation of transcripts and slower mRNA degradation rates. Accumulated transcripts show enhanced uridylation and in vitro Dis3L2 displays a preference for uridylated substrates. Altogether, our results suggest that in S. pombe , and possibly in most other eukaryotes, Dis3L2 is an important factor in mRNA degradation. Therefore, this novel 3′‐5′ RNA decay pathway represents an alternative to degradation by Xrn1 and the exosome. There is a [Have you seen?][1] (July 2013) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2013.136

15 September 2004 in Genes & Development
Verified
Journal Article
Open access
PDF file
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
JCJulia Promisel Cooper
Julia Promisel Cooper
Several considerations suggest that levels of the two major modes of double-strand break (DSB) repair, homologous recombination (HR), and nonhomologous end joining (NHEJ), are regulated through the cell cycle. However, this idea has not been explicitly tested. In the absence of the telomere-binding protein Taz1, fission yeast undergo lethal telomere fusions via NHEJ. These fusions occur only during periods of nitrogen starvation and fail to accumulate during logarithmic growth, when the majority of cells are in G2. We show that G1 arrest is the specific nitrogen starvation-induced event that promotes NHEJ between taz1- telomeres. Furthermore, the general levels of NHEJ and HR are reciprocally regulated through the cell cycle, so that NHEJ is 10-fold higher in early G1 than in other cell cycle stages; the reverse is true for HR. Whereas NHEJ is known to be dispensable for survival of DSBs in cycling cells, we find that it is critical for repair and survival of DSBs arising during G1.

1 January 2001 in Molecular Cell
Verified
Journal Article
Closed access
Miguel Godinho FerreiraMiguel Godinho Ferreira
Miguel Godinho Ferreira
JCJulia Promisel Cooper
Julia Promisel Cooper